The Predictive Value of Clinical Data on Perioperative and Postoperative Risk Events in Patients With Head and Neck Artery Stenosis
Study Details
Study Description
Brief Summary
Predicting relevant risk factors for patients with carotid artery stenosis after different surgeries through machine learning
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Outcome Measures
Primary Outcome Measures
- death [two years]
Patients who died after surgery
Secondary Outcome Measures
- stroke [half a year]
Is there a recurrence of cerebral infarction within six months after surgery
Eligibility Criteria
Criteria
Inclusion Criteria:
- (1) All enrolled patients were diagnosed with clear head and neck artery stenosis and a risk event after head and neck revascularization;
(2) Location of lesion: origin of internal carotid artery, bifurcation of internal and external carotid arteries;
(3) Patients with symptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, and with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 50% found on angiography;
(4) Asymptomatic head and neck artery stenosis and risk events after head and neck revascularization, with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 60% found on angiography;
(5) Asymptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, with a non-invasive examination of stenosis degree less than 70%, but angiography or other examinations indicate that the stenosis lesion is in an unstable state;
(6) Symptomatic head and neck artery stenosis and risk events after head and neck revascularization, non-invasive examination of head and neck artery stenosis and risk event degree after head and neck revascularization at 50% to 69%
Exclusion Criteria:
- (1) Patients with poor overall condition and intolerance to general anesthesia;
(2) Patients with mental illness or severe mental illness;
(3) Severe respiratory system diseases;
(4) Pregnant and lactating women;
(5) Participating in another clinical study;
(6) Patients with advanced tumors or those who are expected to die within one year;
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Tangdu Hospital | Xi'an | Shaanxi | China | 710038 |
Sponsors and Collaborators
- Tang-Du Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- liubei